IRIS
TESSITORE, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.436
EU - Europa 2.533
AS - Asia 2.340
SA - Sud America 371
AF - Africa 33
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.721
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.356
SG - Singapore 1.074
IE - Irlanda 557
CN - Cina 551
IT - Italia 398
BR - Brasile 329
DE - Germania 326
SE - Svezia 292
TR - Turchia 250
HK - Hong Kong 215
RU - Federazione Russa 215
GB - Regno Unito 175
UA - Ucraina 145
FR - Francia 141
FI - Finlandia 131
VN - Vietnam 107
CA - Canada 43
CZ - Repubblica Ceca 40
IN - India 35
MX - Messico 28
BE - Belgio 23
BD - Bangladesh 21
PL - Polonia 20
NL - Olanda 19
ES - Italia 18
JP - Giappone 18
ZA - Sudafrica 18
IQ - Iraq 16
AR - Argentina 12
AT - Austria 8
KR - Corea 8
EC - Ecuador 7
ID - Indonesia 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
PK - Pakistan 5
AU - Australia 4
LT - Lituania 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
CL - Cile 3
EU - Europa 3
JM - Giamaica 3
MA - Marocco 3
NP - Nepal 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
BG - Bulgaria 2
CH - Svizzera 2
DZ - Algeria 2
EE - Estonia 2
GE - Georgia 2
HR - Croazia 2
HU - Ungheria 2
IR - Iran 2
JO - Giordania 2
MY - Malesia 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CD - Congo 1
CM - Camerun 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GF - Guiana Francese 1
GH - Ghana 1
GI - Gibilterra 1
GR - Grecia 1
GY - Guiana 1
IL - Israele 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
MK - Macedonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
SN - Senegal 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 9.721
Salva come PNG Salva come JPEG
Città #
Chandler 622
Dallas 576
Singapore 574
Jacksonville 566
Dublin 553
San Jose 259
Boardman 227
Ashburn 218
Hong Kong 213
Santa Clara 211
Izmir 134
New York 111
Nanjing 98
Beijing 87
Munich 85
Princeton 80
San Mateo 80
Lawrence 79
Wilmington 74
Ann Arbor 73
The Dalles 66
Los Angeles 59
Moscow 56
L'aquila 55
L’Aquila 50
Bremen 45
Woodbridge 43
Helsinki 41
Brno 39
Milan 36
Nanchang 35
São Paulo 32
Ho Chi Minh City 30
Rome 30
Shenyang 29
Dong Ket 28
Seattle 28
Council Bluffs 25
Brussels 23
Shanghai 23
Tianjin 22
Verona 22
Hanoi 21
Aquila 20
Kitzingen 20
Warsaw 20
Montreal 19
Turku 19
Brooklyn 18
Columbus 18
Tokyo 17
Des Moines 15
Houston 15
Jiaxing 15
Johannesburg 15
London 15
Mountain View 15
Casoria 14
Hebei 14
Hefei 14
Kunming 13
Philadelphia 13
Zhengzhou 13
Atlanta 12
Changsha 12
Falkenstein 12
Lappeenranta 11
Lauterbourg 11
Norwalk 11
Phoenix 11
Poplar 11
Mexico City 10
Pune 10
San Francisco 10
Amsterdam 9
Chicago 9
Dearborn 9
Denver 9
Guangzhou 9
Ningbo 9
Orem 9
Assago 8
Jinan 8
Manchester 8
Redwood City 8
Toronto 8
Boston 7
Brasília 7
Campinas 7
Frankfurt am Main 7
Lissone 7
Querétaro 7
Stockholm 7
Taizhou 7
Auburn Hills 6
Bari 6
Berlin 6
Chennai 6
Nuremberg 6
Porto Alegre 6
Totale 6.396
Salva come PNG Salva come JPEG
Nome #
The prevalent KRAS exon 2 c.35 G > A mutation in metastatic colorectal cancer patients: a biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens? 181
new bioinformatics approach to identify target genes for dysregulated micrornas in a chemically-induced hepatocarcinoma mouse model 168
Involvement of an arachidonic-acid-dependent pathway in the interferon-beta-mediated expression of C202 gene in Ehrlich-ascites-tumor cells 160
Bioinformatics approach to predict target genes for dysregulated microRNAs in hepatocellular carcinoma: Study on a chemically-induced HCC mouse model 159
KRAS and Two Rare PI3KCA Mutations Coexisting in a Metastatic Colorectal Cancer Patient With Aggressive and Resistant Disease. 158
EFFECTS OF SAFFRON ON HEPATOCARCINOGENESIS PROCESS: A STUDY ON A MOUSE MODEL 156
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis. 155
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations. 155
Therapeutic Use of MicroRNAs in Cancer 153
Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach? 144
Concurrent RAS and RAS/BRAF V600E variants in colorectal cancer: more frequent than expected? 142
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma 141
Emerging role of isomirs in cancer: State of the art and recent advances 135
MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice 134
mir-182 dysregulation in a diet-induced NAFLD-NASH-hepatocellular carcinoma mouse model 134
Cancer secretome and inflammation: The bright and the dark sides of NF-kB 134
Next-generation sequencing: Recent applications to the analysis of colorectal cancer 131
Low Radiation Environment Switches the Overgrowth-Induced Cell Apoptosis Toward Autophagy 131
MicroRNAs Expression in Response to rhNGF in Epithelial Corneal Cells: Focus on Neurotrophin Signaling Pathway 130
ANALISI DEL miRNoma NELL’EPATOCARCINOMA INDOTTO DA DIETILNITROSAMINA 129
development of hepatocellular cancer in a murine model of nonalcoholic steatohepatitis induced by use of low-fat/high carbohydrate diet 129
Development of hepatocellular cancer induced by long term low fat-high carbohydrate diet in a nafld/nash mouse model 129
Longitudinal monitoring of mRNA levels of regulatory T cell biomarkers by using non-invasive strategies to predict outcome in renal transplantation 128
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 127
two simulteneous and very uncommom pi3kca mutations in a liver metastasis from colorectal cancer patient with aggressive and resistant disease 126
The Role of Circulating MicroRNAs as Biomarkers in NAFLD 120
New mutations and protein variants of NBSI are identified in cancer cell lines 117
Angiotensin II stimulates intercellular adhesion molecule-1(ICAM1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo 117
Serum biomarkers identification by mass spectrometry in high-mortality tumors. 117
Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma 116
Circulating micrornas as prognostic and therapeutic biomarkers in breast cancer molecular subtypes 116
Characterization of a novel HLA-Cw*02 variant, Cw*0208, in a Caucasian individual 113
crosstalk between nf-kb and shh pathways in prostate cancer 113
Two gamma-interferon-activation sites (GAS) on the promoter of the human intercellular adhesion molecule 1 (ICAM-1) gene are required for induction of transcription by IFN-gamma 112
Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide -> dose-dense docetaxel 112
MIRNOME ANALYSIS IN THE PATHOGENESIS OF HEPATOCARCINOMA 111
the role of kctd11 tumor suppressor gene in prostate cancer 111
Novel P53 mutations detected by FAMA in colorectal cancers 108
MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression 107
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status. 107
KCTD11 tumor suppressor gene expression is reduced in prostate adenocarcinoma 107
Prognostic relevance of KRAS genotype and the prevalent C.35 G > a mutation in metastatic colorectal cancer (MCRC) patients fitting for intensive FIr-B/FOx triplet chemotherapy plus bevacizumab 106
Ultrasound-based method for the identification of novel microrna biomarkers in prostate cancer 106
A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: The SynapSES trial 106
A KRAS and dual concomitant PI3KCA mutations in a metastatic colorectal cancer patient with aggressive and resistant disease 105
Codon optimization by 0-1 linear programming 105
The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages. 103
Can analysis of the molecular status of the p53 gene contribute to improving the therapeutic strategy for breast carcinoma? 100
Identification of the uncommon allele HLA-A*7403 in a Caucasian renal transplant cadaveric donor: Extension of the exon 4 sequence 99
Mitotic phosphorylation of Tau/MAPT modulates cell cycle progression in prostate cancer cells 98
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 98
MicroRNAs in the DNA Damage/Repair Network and Cancer 97
Applications of Next Generation Sequencing to the Analysis of Familial Breast/Ovarian Cancer 97
Classification of tumor types using XGBoost machine learning model: a vector space transformation of genomic alterations 96
Human leukocyte antigen-A, -B, and -Cw polymorphism in a Berber population from North Morocco using sequence-based typing 96
A NEW ALLELE, MICA*078, IDENTIFIED IN A MOROCCAN INDIVIDUAL WITH CELIAC DISEASE 96
Takotsubo Syndrome during Pertuzumab and Trastuzumab Therapy for HER2-Positive Metastatic Breast Cancer 96
Identification of the novel allele B*4427 and a confirmatory sequence (B*44022) 94
Pharmacogenetics and clinical oncology: a new deal for personalized therapies 93
MICA∗078: A novel allele identified in a moroccan individual affected by celiac disease. 92
High sensitivity of detectionof TP53 somatic mutations by fluorescence-assisted mismatch analysis 92
A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal Cancer. 91
Prognostic value of p53 molecular status in high-risk primary breast cancer 90
Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition 90
Reverse-phase protein microarray highlights HER2 signaling activation in immunohistochemistry/FISH/HER2-negative breast cancers. 90
Smart hydrogel particles: Biomarker harvesting: One-step affinity purification, size exclusion, and protection against degradation 89
Identification of a novel HLA-DRB1*11 allele: DRB1*1152 88
MiRNome analysis in high-fat diet-induced hepatocarcinoma. 88
Long-term abuse of a high-carbohydrate diet is as harmful as a high-fat diet for development and progression of liver injury in a mouse model of NAFLD/NASH 88
Identification of a novel HLA-A*02 allele, A*027401* 88
Identification of a novel allele variant of HLA-B*57 in a Caucasian Moroccan individual: B*57032 87
Prognostic significance of P53 mutations in high risk node positive breast cancer patients 86
Role of Breast Cancer Risk Estimation Models to Identify Women Eligible for Genetic Testing and Risk-Reducing Surgery 84
Analytical scanning of p53 mutations by FAMA (fluorescence assisted mismatch analysis) in colorectal cancers and preliminary prognostic findings. 84
Neuroprotective effects of human amniotic fluid stem cells-derived secretome in an ischemia/reperfusion model 83
Increased CD1D polymorphism: identification of two novel alleles, CD1D*03 and *04, in individuals from Morocco. 82
Serum low-molecular-weight protein fractionation for biomarker discovery 82
A method to comprehensively identify germline SNVs, INDELs and CNVs from whole exome sequencing data of BRCA1/2 negative breast cancer patients 81
SMO-M2 mutation does not support cell-autonomous Hedgehog activity in cerebellar granule cell precursors 81
Role of bcr-abl in the regulation and inhibition of apoptosis 80
Prenatal diagnosis of a rhodopsin mutation using chemical cleavage of the mismatch 79
MicroRNA profiling in women with migraine: effects of CGRP-targeting treatment 79
Mass spectrometry driven discovery proteomics of serum from mice with human ovarian cancer resulted in identification of a potential cancer-origin biomarker that correlates with peritoneal tumor burden. 78
Efficacy and tolerability of Everolimus-Exemestane combination therapy in metastatic breast cancer patients: experience in Real Life 78
Ultrasound as a New Method for the Release and Identification of Novel microRNAs and Proteins as Candidate Biomarkers in Pancreatic Cancer 77
An initial characterization of the serum phosphoproteome. 76
MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors 74
IDENTIFICATION OF TWO NOVEL ALLELES, CD1D*03 AND*04, IN INDIVIDUALS FROM MOROCCO 72
Role of the Molecular Tumor Board for the Personalized Treatment of Patients with Metastatic Breast Cancer: A Focus on the State of the Art in Italy 68
MicroRNAs expression analysis in high-fat diet induced NAFLD-NASH-HCC progression: study on C57BL/6J mice 61
Role of Circulating microRNAs in Liver Disease and HCC: Focus on miR-122 58
General Direct Anticancer Effects of Deer Growing Antler Extract in Several Tumour Cell Lines, and Immune System-Mediated Effects in Xenograft Glioblastoma 57
Detection of NBS1 (Nibrin) mutations in breast and ovarian cancer 56
null 38
null 35
Totale 9.966
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.429
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.429
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021449 0 0 0 0 0 0 99 39 83 39 129 60
2021/2022514 35 25 128 43 21 5 9 28 35 9 33 143
2022/20231.684 106 125 30 213 167 184 2 86 682 11 56 22
2023/2024474 46 26 19 41 31 118 2 45 0 18 29 99
2024/20251.993 83 62 228 103 193 158 278 188 366 68 137 129
2025/20262.650 218 387 442 544 417 305 337 0 0 0 0 0
Totale 9.966